Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Mark Andrejeski, Longtime ACR Executive Vice President, Retiring

Susan Bernstein  |  Issue: April 2019  |  April 15, 2019

Proudest Achievements

Mark Andrejeski, Tobé Malawista, Arthur Weaver, MD, and Stanley Cohen, MD

Mark Andrejeski,
Tobé Malawista,
Arthur Weaver, MD, and Stanley Cohen, MD

One of Mr. Andrejeski’s proudest achievements was increasing the pipeline of rheumatology trainees, which had dipped in the ’90s. Young physicians did not want to practice in a field that had few therapies available to help their patients.

“Biologics changed all that. All of a sudden, rheumatologists became the leaders in biological therapy. We had more interest from trainees,” he says. “Our leaders at the time had the wisdom to go to industry and say, ‘There is a dearth of rheumatologists. If you want your therapies to be utilized to help the most patients, you’ll need more rheumatologists.’” The Foundation funded its first rheumatology fellowships in 2002, and in 2019, there will be close to 250 rheumatology trainees starting fellowships.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Mr. Andrejeski also cites the launch of the Rheumatology Informatics System for Effectiveness (RISE) registry as a source of pride (see “The RISE Registry,” p. 27). “Rheumatologists need to record and measure what is going on with patient progress. That’s a message I want to send: Measure, measure, measure. RISE hasn’t yet scratched the surface of its possibilities, but it is a powerful tool. A rheumatologist and friend, Antony Rosen, MD, from John Hopkins once said to me, ‘Man, as a species, loves tools.’ We have to figure out how to benefit the most from this incredible tool.”

Retirement Plans

One of Mr. Andrejeski’s longtime staff members, Ron Olejko, retired last year after working for the ACR for more than 40 years—since 1975. He remembers the concern many had that the new association wouldn’t survive. Instead, it thrived under Mr. Andrejeski’s watch.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“Due to Mark’s financial acumen, the ACR is now financially stable and a major supporter of rheumatology research. Among Mark’s many talents is his ability to hire the best people for the job and then allow them the freedom to excel in those jobs,” says Mr. Olejko. But the Ohio native and Cleveland Browns fan adds, “Mark does have one major flaw: He’s a Steelers fan.”

What will Mr. Andrejeski do in retirement? He has no idea.

“I’m looking forward to finding out. I just want to figure it out as it happens. I’ve traveled to so many great places while I have worked here, so I don’t even know if travel is that high on my list,” he says. “I’m going to try to get back into my golf game. That’s one of the reasons I wanted to move here to Atlanta. The weather allows you to play golf so much of the year.”

Why retire now? It’s the right time,
he says.

“People always say, ‘If you look at yourself in the mirror and say, ‘It’s time to retire,’ you know it’s time. You just know.”

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:From the CollegeProfiles Tagged with:American College of Rheumatology (ACR)Mark Andrejeski

Related Articles

    An Expression of Gratitude: The Presidents’ Farewell to Mark Andrejeski

    May 17, 2019

    Sometimes it’s hard to get a song out of your head, especially when you can’t recall all the lyrics and struggle to find the words to fill in the blanks. That’s what happened to me when I started to write this column. A song, probably too dated now for many to find particularly compelling, kept…

    Late Spring 2021’s Awards, Appointments & Announcements in Rheumatology

    April 17, 2021

    AMA Honors Mark Andrejeski with Lifetime Achievement Award In November 2020, the American Medical Association (AMA) presented Mark Andrejeski, the recently retired executive vice president of the ACR, with its Medical Executive Lifetime Achievement Award. The award honors a medical association executive who has contributed substantially to the goals and ideals of the medical profession….

    A New Home for the ACR

    November 1, 2009

    The Atlanta headquarters are moving to a building purchased by the College

    Ron Olejko Retires from the ACR

    July 19, 2018

    Each fall, the ACR/ARHP Annual Meeting takes place in a major U.S. city. More than 15,000 people fill the cavernous halls of the area convention center and nearby hotels to attend scientific and educational sessions, scan the latest data on posters and mingle with colleagues at the annual Presidents’ Reception. What most attendees may not…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences